BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 18972587)

  • 1. Therapeutic modulation of apoptosis: targeting the BCL-2 family at the interface of the mitochondrial membrane.
    Nemec KN; Khaled AR
    Yonsei Med J; 2008 Oct; 49(5):689-97. PubMed ID: 18972587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial carrier homolog 2: a clue to cracking the BCL-2 family riddle?
    Gross A
    J Bioenerg Biomembr; 2005 Jun; 37(3):113-9. PubMed ID: 16167168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulating mitochondria-mediated apoptotic cell death through targeting of Bcl-2 family proteins.
    Aouacheria A; Cibiel A; Guillemin Y; Gillet G; Lalle P
    Recent Pat DNA Gene Seq; 2007; 1(1):43-61. PubMed ID: 19075918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mystery of BCL2 family: Bcl-2 proteins and apoptosis: an update.
    Siddiqui WA; Ahad A; Ahsan H
    Arch Toxicol; 2015 Mar; 89(3):289-317. PubMed ID: 25618543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bid: a Bax-like BH3 protein.
    Billen LP; Shamas-Din A; Andrews DW
    Oncogene; 2008 Dec; 27 Suppl 1():S93-104. PubMed ID: 19641510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BH3-only proteins and their roles in programmed cell death.
    Giam M; Huang DC; Bouillet P
    Oncogene; 2008 Dec; 27 Suppl 1():S128-36. PubMed ID: 19641498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robust lanthanide-based assays for the detection of anti-apoptotic Bcl-2-family protein antagonists.
    Rega MF; Reed JC; Pellecchia M
    Bioorg Chem; 2007 Apr; 35(2):113-20. PubMed ID: 16996562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Bid to prevent programmed cell death in neurons.
    Culmsee C; Plesnila N
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):1334-40. PubMed ID: 17073814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bcl-2 family of proteins as drug targets for cancer chemotherapy: the long way of BH3 mimetics from bench to bedside.
    Vela L; Marzo I
    Curr Opin Pharmacol; 2015 Aug; 23():74-81. PubMed ID: 26079328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis regulation at the mitochondrial outer membrane.
    Gillies LA; Kuwana T
    J Cell Biochem; 2014 Apr; 115(4):632-40. PubMed ID: 24453042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subversion of the Bcl-2 life/death switch in cancer development and therapy.
    Adams JM; Huang DC; Strasser A; Willis S; Chen L; Wei A; van Delft M; Fletcher JI; Puthalakath H; Kuroda J; Michalak EM; Kelly PN; Bouillet P; Villunger A; O'Reilly L; Bath ML; Smith DP; Egle A; Harris AW; Hinds M; Colman P; Cory S
    Cold Spring Harb Symp Quant Biol; 2005; 70():469-77. PubMed ID: 16869785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial cell death effectors.
    Brenner D; Mak TW
    Curr Opin Cell Biol; 2009 Dec; 21(6):871-7. PubMed ID: 19822411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signal transduction mediated by Bid, a pro-death Bcl-2 family proteins, connects the death receptor and mitochondria apoptosis pathways.
    Yin XM
    Cell Res; 2000 Sep; 10(3):161-7. PubMed ID: 11032168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of proapoptotic molecules Bax and Bak in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced mitochondrial disruption and apoptosis: differential regulation of cytochrome c and Smac/DIABLO release.
    Kandasamy K; Srinivasula SM; Alnemri ES; Thompson CB; Korsmeyer SJ; Bryant JL; Srivastava RK
    Cancer Res; 2003 Apr; 63(7):1712-21. PubMed ID: 12670926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Bcl-2-associated death promoter (BAD) lowers the threshold at which the Bcl-2-interacting domain death agonist (BID) triggers mitochondria disintegration.
    Howells CC; Baumann WT; Samuels DC; Finkielstein CV
    J Theor Biol; 2011 Feb; 271(1):114-23. PubMed ID: 21130780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of E1B 19K with Bax is required to block Bax-induced loss of mitochondrial membrane potential and apoptosis.
    Han J; Modha D; White E
    Oncogene; 1998 Dec; 17(23):2993-3005. PubMed ID: 9881701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptotic machinery: the Bcl-2 family proteins in the role of inspectors and superintendents.
    Tichý A
    Acta Medica (Hradec Kralove); 2006; 49(1):13-8. PubMed ID: 16696437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow Cytometry-Based Detection and Analysis of BCL-2 Family Proteins and Mitochondrial Outer Membrane Permeabilization (MOMP).
    Ludwig LM; Maxcy KL; LaBelle JL
    Methods Mol Biol; 2019; 1877():77-91. PubMed ID: 30535999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone differentially regulates Bcl-2 family proteins in human proliferative chondrocytes: role of pro-apoptotic Bid.
    Zaman F; Chrysis D; Huntjens K; Chagin A; Takigawa M; Fadeel B; Sävendahl L
    Toxicol Lett; 2014 Jan; 224(2):196-200. PubMed ID: 24172751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bax and other pro-apoptotic Bcl-2 family "killer-proteins" and their victim the mitochondrion.
    Antonsson B
    Cell Tissue Res; 2001 Dec; 306(3):347-61. PubMed ID: 11735035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.